348340 — Neuromeka Co Income Statement
0.000.00%
Last trade - 00:00- KR₩286bn
- KR₩321bn
- KR₩25bn
Annual income statement for Neuromeka Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,066 | 7,351 | 9,755 | 13,743 | 25,269 |
| Cost of Revenue | |||||
| Gross Profit | 248 | 1,837 | 1,152 | 1,222 | 4,139 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 12,220 | 10,360 | 17,553 | 28,568 | 44,284 |
| Operating Profit | -8,154 | -3,009 | -7,798 | -14,825 | -19,015 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8,271 | -6,594 | -8,201 | -17,646 | -16,724 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -8,271 | -6,594 | -8,201 | -17,654 | -16,755 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8,271 | -6,594 | -8,201 | -17,654 | -16,755 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8,271 | -6,594 | -8,201 | -17,654 | -16,755 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -839 | -667 | -953 | -1,689 | -1,589 |
| Dividends per Share |